Clinical Trial Update: A Study on the Efficacy and Gut Microbiota of Berberine and Probiotics in Patients With Newly Diagnosed Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and gut microbiota effects of berberine and probiotics in newly diagnosed Type 2 diabetes patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Berberine (berberine)
• Probiotics

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Type 2 Diabetes | Phase 3 | Status: UNKNOWN